Related Experiment Video
Updated: Jun 21, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Prevalence and severity of anemia in pediatric hemodialysis patients
Afshin Azhir1, Jafar Nasiri, Alaleh Gheisari
1Department of Pediatrics, Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran. azhir@med.mui.ac.ir
Insights
Anemia is highly prevalent in children undergoing hemodialysis, particularly those on dialysis for less than six months. Low albumin and severe hyperparathyroidism are key predictors of anemia in this pediatric population.
Area of Science:
- Pediatric Nephrology
- Hematology
- Clinical Medicine
Background:
- Anemia is a common complication in children requiring hemodialysis.
- Understanding anemia predictors is crucial for effective management in pediatric patients.
Purpose of the Study:
- To determine the prevalence and severity of anemia in children on hemodialysis.
- To identify independent predictors of anemia in this patient group.
Main Methods:
- A cross-sectional study was conducted on 25 children (aged 7-20 years) undergoing hemodialysis.
- Data collected included hemoglobin levels, duration of dialysis, serum albumin, and intact parathyroid hormone (iPTH) levels.
Main Results:
- 82% of patients had anemia (hemoglobin <11 g/dL), with 48% experiencing severe anemia (hemoglobin <8 g/dL).
- Anemia was more prevalent and severe in children on dialysis for <6 months.
- Low serum albumin and high iPTH levels (>200 pg/mL) were significantly correlated with lower hemoglobin levels.
Conclusions:
- The prevalence of anemia in this pediatric hemodialysis cohort is high, despite treatment with recombinant human erythropoietin (rHuEPO) and iron supplementation.
- Short duration of dialysis (<6 months), low serum albumin, and severe hyperparathyroidism are significant predictors of anemia.
- Further research into optimizing anemia management strategies for pediatric hemodialysis patients is warranted.
Objective:
To determine the prevalence and severity of anemia, and to identify independent predictors for anemia in children on hemodialysis.
Methods:
We conducted this cross sectional study on 25 children aged 7-20 years receiving hemodialysis from September 2005 to January 2006 in Isfahan University of Medical Sciences, Isfahan, Iran.
Results:
A total of 22 (82%) patients had hemoglobin (Hb) level of <11 g/dL (anemia) and 12 (48%) patients had Hb values <8 g/dL (severe anemia). The mean age was 15.5 +/- 3.7 years. Mean time on hemodialysis was 20.44 +/- 15.25 months. Anemia was more common and severe among children who were on dialysis <6 months. There was an inverse relation between severity of anemia and duration of hemodialysis (r=-0.465, p=0.019). Nearly all patients were treated with recombinant human erythropoietin (rHuEPO). Children with severe anemia received a slightly higher dose of erythropoietin (r=0.202 p=0.09). There was a correlation between serum albumin and Hb level (r=0.511, p=0.01). Intact parathyroid hormone (iPTH) levels were >200 pg/mL in 16 patients (66%) and >400 pg/mL in 9 patients (37.5%). There was a reverse correlation between iPTH level >200 pg/mL and Hb level (r=-0.505, p=0.046).
Conclusion:
The prevalence of anemia in our study appears to be higher than that reported in the other studies in spite of extensive use of rHuEPO and iron supplementation. We found this to be especially true for patients who were on dialysis <6 months and with low albumin and severe hyperparathyroidism.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Peritoneal Dialysis III: Nursing Management
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations

